Back to MRK

Merck & Co., Inc. Share-Based Compensation 2007-2026 | MRK

Beta

What is share-based compensation?

Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.

What is Merck & Co., Inc.'s current share-based compensation?

Merck & Co., Inc. (MRK) annual share-based compensation for 2025 was $820.0M, a 7.75% increase from 2024. Merck & Co., Inc. share-based compensation for the quarter ending March 31, 2026 was $185.0M.

What was Merck & Co., Inc.'s share-based compensation in 2024?

Merck & Co., Inc. annual share-based compensation for 2024 was $761.0M, a 17.98% increase from 2023.

What was Merck & Co., Inc.'s share-based compensation in 2023?

Merck & Co., Inc. annual share-based compensation for 2023 was $645.0M, a 19.22% increase from 2022.

What is Merck & Co., Inc.'s 5-year share-based compensation CAGR?

Merck & Co., Inc. share-based compensation grew at a compound annual growth rate (CAGR) of 13.21% from FY2020 to FY2025, going from $441.0M to $820.0M over 5 years.

Share-Based Compensation History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+13.2%
FY2020
$441.0M
→
FY2025
$820.0M
07080910111213141516171819202122232425
5 years selected
Share-Based Compensation History
PeriodValueChangeSource
FY2025$820.0M+7.8%10-K
FY2024$761.0M+18.0%10-K
FY2023$645.0M+19.2%10-K
FY2022$541.0M+12.9%10-K
FY2021$479.0M+8.6%10-K
FY2020$441.0M+13.7%10-K
FY2019$388.0M+11.5%10-K
FY2018$348.0M+11.5%10-K
FY2017$312.0M+4.0%10-K
FY2016$300.0M+0.3%10-K
FY2015$299.0M+7.6%10-K
FY2014$278.0M+0.7%10-K
FY2013$276.0M-17.6%10-K
FY2012$335.0M-9.2%10-K
FY2011$369.0M-27.5%10-K
FY2010$509.0M+22.7%10-K
FY2009$415.0M+19.3%10-K
FY2008$348.0M+5.4%10-K
FY2007$330.2M-10-K
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →